Abstract

Background/aimCarbapenem-resistantKlebsiella pneumoniae (CR-KP) infections encountered in urology patients differentiate from infections caused by other factors, both in respect to prophylaxis and treatment stage, and require a special approach. We aimed to analyse the predisposing factors and the antibiotherapies for CR-KP infection outbreak in a tertiary urology clinic.Materials and methods There were 75 patients in the CR-KP positive group (Group I) and 146 patients in the CR-KP negative group (Group II). Analysis of the predisposing factors for CR-KP infection and comparison of the reinfection rate and the antibiotherapies in the 2 groups were the endpoints.ResultsIn the first group, age, comorbidity, previous antibiotic use, and nephrostomy tube rates were higher (P = 0.015, P = 0.001, P = 0.004, and P < 0.001, respectively). In the second group, open urological surgery rate, and the proportion of patients presenting with flank pain, lower urinary tract symptoms, and haematuria were higher (P = 0.029, P < 0.001, P < 0.001, and P = 0.007). In the first group, the proportion of patients treated with transurethral bladder tumour resection was higher, whereas, percutaneous nephrolithotomy was higher in the second group (P = 0.045 for both). While hospitalization and Foley catheterization duration were longer in the first group (P < 0.001 for both), double J stent and nephrostomy duration were longer in the second group (P < 0.001 and P = 0.005). Mean leukocyte count at admission was higher in the first group (P < 0.001).Conclusion Advanced age, comorbidities, previous antibiotic use, and prolonged Foley catheterization duration are predisposing factors for this infection in the urology department. Two-week administration of combination antibiotic regimens containing carbapenem were effective for the treatment of this infection.

Highlights

  • World-wide increased antibiotic resistance is a global threat to the health system

  • While hospitalization and Foley catheterization duration were longer in the first group (P < 0.001 for both), double J stent and nephrostomy duration were longer in the second group (P < 0.001 and P = 0.005)

  • Six patients whose data were not able to reach in the Carbapenem-resistant Klebsiella pneumonia (CRKP) group and 5 patients in the non-Carbapenem-resistant Klebsiella pneumoniae (CR-KP) group were excluded from the study, and the remaining 221 patients were included in the study

Read more

Summary

Introduction

World-wide increased antibiotic resistance is a global threat to the health system. Carbapenem-resistant gram-negative bacteria have become quite another multiresistant infectious agent with limited treatment options. Carbapenem-resistant Klebsiella pneumonia (CRKP) hydrolyses carbapenems via β-lactamase enzyme and shows resistance to many antimicrobial agents [1,2]. These organisms have resistance mechanisms for the second line antibiotics. It has been demonstrated that they may show resistance to the last option antibiotics such as tigecycline and colistin [3,4,5]. The importance of antibiotic stewardship in the management of patients has been highlighted and practical guidelines have been developed

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call